← Eichor
Condition: Heart Failure Preserved Ejection Fraction Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Heart Failure Preserved Ejection Fraction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial
NA · 2 location(s) · University Medical Center Groningen · NCT06065124Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fraction (HFpEF) Pilot Study
NA · 1 location(s) · Cardioangiologisches Centrum Bethanien · NCT07385417EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT07202000LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · 92 location(s) · Tenax Therapeutics, Inc. · NCT07288398Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
NA · 1 location(s) · University of Michigan · NCT06337812The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction
NA · 1 location(s) · University of Oxford · NCT05878912Study on Heart Failure with Preserved Ejection Fraction with Qishen Granules
NA · 2 location(s) · Guangdong Provincial Hospital of Traditional Chinese Medicin · NCT06377761Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study
NA · 2 location(s) · Universita di Verona · NCT06826963Renal Denervation in Patients With Chronic Heart Failure With Preserved Ejection Fraction
NA · 1 location(s) · Xinjiang Medical University · NCT05715697Selenium Intervention Registry Randomized Trial in Heart Failure
Phase 3 · 11 location(s) · Skane University Hospital · NCT07543562Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction
Phase 1 · 2 location(s) · Sardocor Corp. · NCT06061549PBMC as Biomarkers of Diabetic Cardiomyopathy
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT05651919Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
NA · 8 location(s) · Medtronic Cardiac Rhythm and Heart Failure · NCT05839730A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety
NA · 3 location(s) · Pulnovo Medical, Inc. · NCT07214376Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Phase N/A · 1 location(s) · University of Edinburgh · NCT06409585Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Phase N/A · 1 location(s) · Herlev and Gentofte Hospital · NCT04950218Diagnosis and OutcoMes evaluAtIoN of Multicenter Patients With HFpEF Using Multimodality Imaging
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT04602338ELEVATE-HFpEF Clinical Study
NA · 46 location(s) · Medtronic Cardiac Rhythm and Heart Failure · NCT06678841CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
Phase 2 · 1 location(s) · Mayo Clinic · NCT06762964A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflamma
Phase 3 · 240 location(s) · Novo Nordisk A/S · NCT06200207A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
Phase 2 · 1 location(s) · Mayo Clinic · NCT07083011Leg Heat Therapy in Heart Failure With Preserved Ejection Fraction
NA · 2 location(s) · Indiana University · NCT06388226HFPEF-project: Heart Failure Phenotyping - Exploring the Fingerprints
Phase N/A · 1 location(s) · University of Helsinki · NCT06465043Exercise Intolerance in Heart Failure
Phase N/A · 1 location(s) · Johns Hopkins University · NCT03775577A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
Phase 2 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT06862908Transitions of Care Clinic (TOCC)
NA · 1 location(s) · Hackensack Meridian Health · NCT06937827Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
Phase 4 · 1 location(s) · University of Virginia · NCT07178145A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase 3 · 652 location(s) · Boehringer Ingelheim · NCT06424288Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
Phase N/A · 6 location(s) · Northwestern University · NCT06517186SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
Phase 2 · 1 location(s) · University of Pennsylvania · NCT05138575
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.